Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equine Anti-SARS-CoV-2 Serum Formulations in Hospitalized COVID-19
NCT04610502Phase 2Completed
- Sponsor
- Caja Costarricense de Seguro Social
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Caja Costarricense de Seguro Social. Primary endpoints: Efficacy and Safety of two formulations and Safety of two formulations at 3 months. Started Sep 2020; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04610502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04610502.